Manuel Reina
Corporate Officer/Principal presso University of Barcelona
Profilo
Manuel Reina is a Director of Advanced In Vitro Cell Technologies SL.
He is an Associate Professor of Cell Biology at the University of Barcelona.
He is a Co-Director of Celltec UB and a Member of the Origami Society.
Dr. Reina received a PhD in Molecular Biology from CSIC, Barcelona.
Posizioni attive di Manuel Reina
| Società | Posizione | Inizio |
|---|---|---|
| University of Barcelona | Corporate Officer/Principal | - |
Precedenti posizioni note di Manuel Reina
| Società | Posizione | Fine |
|---|---|---|
Advancell Advanced In Vitro Cell Technologies SL
 Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Direttore/Membro del Consiglio | - |
Formazione di Manuel Reina
| Consejo Superior de Investigaciones Científicas | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Advancell Advanced In Vitro Cell Technologies SL
Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Health Technology |
- Borsa valori
- Insiders
- Manuel Reina